{"title":"Discovery of the expression of HK2 gene in clear cell carcinoma of the kidney and its clinical significance based on database analysis","authors":"Wei Li","doi":"10.3760/CMA.J.ISSN.1673-4181.2019.05.007","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the association between hexokinase 2 (HK2) gene expression and clinical pathological characteristics in renal clear cell carcinoma using database and bioinformatics methods. \n \n \nMethods \nOncomine database was used to analyze the most significant differentially expressed genes between renal clear cell carcinoma and non-kidney tissue. The expression levels of mRNA and protein were detected by GPEIA and The Human Protein Atlas database. Correlation of HK2 expression level between clinicopathological features and prognosis of renal clear cell carcinoma was analyzed using LinkedOmics and KM-plotter databases, respectively. The STRING database was used to predict the potential protein interaction mechanism. \n \n \nResults \nThe most significant difference protein in renal clear cell carcinoma, i.e. HK2, was found, which was highly expressed in renal clear cell carcinoma tissues, and positively correlated with pathological stage, T stage and N stage of renal cell carcinoma (all P<0.05). The overall survival rate of the renal clear cell carcinoma patients with high expression of HK2 was significantly lower than that of the patients with low expression (P<0.05). \n \n \nConclusions \nHigh expression of HK2 gene may be associated with pathological staging, high T stage, high N stage, and poor prognosis of renal clear cell carcinoma. \n \n \nKey words: \nRenal clear cell carcinoma; Hexokinase 2; Bioinformatics","PeriodicalId":61751,"journal":{"name":"国际生物医学工程杂志","volume":"42 1","pages":"398-403"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"国际生物医学工程杂志","FirstCategoryId":"1087","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-4181.2019.05.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To analyze the association between hexokinase 2 (HK2) gene expression and clinical pathological characteristics in renal clear cell carcinoma using database and bioinformatics methods.
Methods
Oncomine database was used to analyze the most significant differentially expressed genes between renal clear cell carcinoma and non-kidney tissue. The expression levels of mRNA and protein were detected by GPEIA and The Human Protein Atlas database. Correlation of HK2 expression level between clinicopathological features and prognosis of renal clear cell carcinoma was analyzed using LinkedOmics and KM-plotter databases, respectively. The STRING database was used to predict the potential protein interaction mechanism.
Results
The most significant difference protein in renal clear cell carcinoma, i.e. HK2, was found, which was highly expressed in renal clear cell carcinoma tissues, and positively correlated with pathological stage, T stage and N stage of renal cell carcinoma (all P<0.05). The overall survival rate of the renal clear cell carcinoma patients with high expression of HK2 was significantly lower than that of the patients with low expression (P<0.05).
Conclusions
High expression of HK2 gene may be associated with pathological staging, high T stage, high N stage, and poor prognosis of renal clear cell carcinoma.
Key words:
Renal clear cell carcinoma; Hexokinase 2; Bioinformatics
目的应用数据库和生物信息学方法分析肾透明细胞癌己糖激酶2 (HK2)基因表达与临床病理特征的关系。方法利用Oncomine数据库分析肾透明细胞癌与非肾组织间最显著差异表达基因。通过GPEIA和The Human protein Atlas数据库检测mRNA和蛋白的表达水平。应用LinkedOmics和KM-plotter数据库分别分析HK2表达水平与肾透明细胞癌临床病理特征和预后的相关性。利用STRING数据库预测潜在的蛋白相互作用机制。结果肾透明细胞癌组织中差异最显著的蛋白为HK2,该蛋白在肾透明细胞癌组织中高表达,与肾透明细胞癌病理分期、T分期、N分期呈正相关(均P<0.05)。高表达HK2的肾透明细胞癌患者的总生存率显著低于低表达患者(P<0.05)。结论HK2基因的高表达可能与肾透明细胞癌的病理分期、高T分期、高N分期及预后不良有关。关键词:肾透明细胞癌;己糖激酶2;生物信息学